Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
Cara Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 22, 2022
Cara Therapeutics reported fiscal year 2020 executive compensation information on April 22, 2022.
In 2020, five executives at Cara Therapeutics received on average a compensation package of $1.7M, a 19% decrease compared to previous year.
Average pay of disclosed executives at Cara Therapeutics
Derek Chalmers, Chief Executive Officer, received $2.9M in total, which decreased by 15% compared to 2019. 37% of Chalmers' compensation, or $1.1M, was in option awards. Chalmers also received $87K in bonus, $346K in non-equity incentive plan, $577K in salary, $818K in stock awards, as well as $11K in other compensation.
Thomas Reilly, Chief Financial Officer, received a compensation package of $1.6M. 89% of the compensation package, or $1.4M, was in option awards.
Frédérique Menzaghi, Chief Scientific Officer, earned $1.4M in 2020, a 38% decrease compared to previous year.
Joana Goncalves, Chief Medical Officer, received $1.3M in 2020.
Scott Terrillion, General Counsel, earned $1.2M in 2020, a 14% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2022.